B A R O S
Skip to main content

Baros Surgery

Procedure Overview

  • PROCEDURE TYPE: Metabolic Surgery
  • TECHNICAL APPROACH: Laparoscopy / SILS / Robotic
  • SURGERY DURATION: 50–60 Minutes
  • FULL RECOVERY: 3–4 Weeks
  • WEIGHT LOSS: 65–80% Excess Weight
  • COMORBIDITY RESOLUTION: 65–85%
Metabolic Surgery

Strong Metabolic Impact with Sleeve Gastrectomy

DJB-SG combines sleeve gastrectomy with bypass of the duodenum to the distal part of the proximal small bowel, producing strong metabolic and hormonal effects. This procedure is particularly effective at improving Type 2 diabetes and insulin resistance — targeting the root metabolic dysfunction.

DJB, commonly performed as a metabolic procedure for control of diabetes by performing a sleeve and adding a bypass between proximal to distal small intestine and help with control of obesity related diseases along with significant lasting weight loss.

01. Who It's For

DJB-SG is recommended for patients where metabolic disease resolution is the primary objective, alongside meaningful weight loss — particularly those with Type 2 diabetes and insulin resistance.

  • BMI >30 with Type 2 diabetes or severe insulin resistance
  • Patients where metabolic improvement is the primary goal
  • Obesity-related metabolic syndrome requiring hormonal correction
  • Candidates who need both weight loss and diabetes resolution

02. How It Works

DJB-SG works through a combination of gastric restriction and duodenal bypass, producing powerful hormonal and metabolic changes that go far beyond simple calorie restriction.

Sleeve Gastrectomy

The stomach is reduced to a sleeve, restricting food intake and reducing hunger hormones.

Duodenal Bypass

Food bypasses the duodenum to the distal proximal small bowel, triggering strong metabolic changes.

Hormonal Modulation

Enhanced incretin response improves insulin secretion and glucose metabolism fundamentally.

Diabetes-Targeting Design

Specifically engineered to target obesity-related Type 2 diabetes and insulin resistance.

03. Expected Outcomes

DJB-SG delivers strong metabolic outcomes alongside effective weight loss. Patients at Baros Apollo can expect:

  • Significant improvement in Type 2 diabetes and insulin resistance
  • 65–80% excess weight loss through combined restriction and bypass
  • 65–85% resolution of obesity-related comorbidities
  • Long-term follow-up and supplementation required post-surgery

India’s leading bariatric & metabolic surgery centre at Apollo Hospitals, Chennai. Expert surgical care, proven outcomes, and lifelong support

Contact Info: